SCHEMBL5281409

SCHEMBL5281409

c1ccc2c(c1)COS2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1588593 0.76 CA12 (0.35)
SCHEMBL29835902 0.76
SCHEMBL31337691 0.76 ALDH1A1 (0.43)
SCHEMBL4511352 0.73 TSHR (0.42)
SCHEMBL29861425 0.67 RYR2 (0.39)
SCHEMBL219847 0.67 RYR2 (0.39)
SCHEMBL317331 0.67 RYR2 (0.31)
SCHEMBL9447237 0.66 KDM4E (0.38)
SCHEMBL13700592 0.65 RYR2 (0.34)
SCHEMBL10641354 0.65 OXTR (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2643295-B1 GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS CHIESI FARMA SPA (IT) 2016-04-13 EP claimed
EP-2797910-B1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMA SPA (IT) 2015-09-16 EP claimed
EP-2797910-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF Chiesi Farmaceutici S.p.A. (IT) 2014-11-05 EP claimed
US-8772314-B2 Glycine derivatives and medicinal compositions thereof CHIESI FARMACEUTICI S.P.A. (IT) 2014-07-08 US claimed
EP-2643295-A1 GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS Chiesi Farmaceutici S.p.A. (IT) 2013-10-02 EP claimed
WO-2013098145-A1 QUINUCLIDINE ESTERS OF 1-AZAHETEROCYCLYLACETIC ACID AS ANTIMUSCARINIC AGENTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-04 WO claimed
US-20120134934-A1 GLYCINE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2012-05-31 US claimed
WO-2012069275-A1 GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS CHIESI FARMACEUTICI S.P.A. (IT) 2012-05-31 WO claimed
EP-1778652-A2 COMPOSITIONS AND METHODS COMPRISING PROTEINASE ACTIVATED RECEPTOR ANTAGONISTS EntreMed, Inc. (US) 2007-05-02 EP claimed
US-7132224-B2 Amplificated photoresist; acid generator which generated acid when exposure to radiation and lactone; immersion in solution of perfluoropolyether MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2006-11-07 US claimed
US-20060063930-A1 Compositions and methods comprising proteinase activated receptor antagonists ENTREMED, INC. 2006-03-23 US claimed
WO-2006023844-A2 COMPOSITIONS AND METHODS COMPRISING PROTEINASE ACTIVATED RECEPTOR ANTAGONISTS ENTREMED, INC. (US) 2006-03-02 WO claimed
US-20250367165-A1 EMERGENCY EYE WASH LEBRUN LABS LLC (US) 2025-12-04 US disclosed
US-20250262123-A1 EMERGENCY EYE WASH LEBRUN LABS LLC 2025-08-21 US disclosed
WO-2024189634-A1 HIGHLY ATOM ECONOMICAL PROCESS FOR SYNTHESIS OF NOVEL CO-INITIATOR FOR PHOTO-INDUCED RADICAL POLYMERISATION SHIV NADAR (INSTITUTION OF EMINENCE DEEMED TO BE UNIVERSITY) (IN) 2024-09-19 WO disclosed
CN-117677497-A Laminate of inorganic substrate and heat-resistant polymer film 东洋纺株式会社 2024-03-08 CN disclosed
US-4620870-A HERBICIDES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-11-04 US disclosed
EP-0197521-A2 Immunoglobulin adsorbent and adsorption apparatus TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) 1986-10-15 EP disclosed
US-4586950-A HERBICIDES E. I. DU PONT DE NEMOURS & COMPANY (US) 1986-05-06 US disclosed
EP-0107979-A1 Novel phenyl-substituted sulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-05-09 EP disclosed